Roche Holding Ag’s experimental drug giredestrant reduced the risk of breast cancer worsening by almost two thirds in some patients with an advanced form of the disease.
www.bloomberg.com
#Roche #Breast #Cancer #Drug #Delays #Progression #Months
Roche Breast Cancer Drug Delays Progression by Over Four Months
